Chart calendar Cerevel Therapeutics Holdings, Inc.

6cd5b88ecbc91c29.T4-X-w9wA6gLOYPmTRhevmq8lWcxvoLCz_TAwvi3Vpg.Pr7mkGciU5FzbOaTGUFq-DzE-C8F99GjhZH5iIzhAfMJ9cO0Rhdlzz1D2g~5a92dbc5313a978d4afbf76fc4e80986

Upcoming events on Cerevel Therapeutics Holdings, Inc.

No events available

Past events on Cerevel Therapeutics Holdings, Inc.

2024-02-16 09:00 am Extraordinary Shareholders Meeting
2023-11-30 09:10 am Evercore ISI HealthCONx Conference
2023-11-14 04:00 am Jefferies London Healthcare Conference
2023-11-01 08:00 am Q3 2023 Earnings Call
2023-11-01 06:30 am Q3 2023 Earnings Release
2023-09-12 09:30 am Morgan Stanley Global Healthcare Conference - Fireside Chat
2023-08-02 08:00 am Q2 2023 Earnings Call
2023-08-02 06:30 am Q2 2023 Earnings Release
2023-06-07 09:00 am Annual General Meeting
2023-05-10 01:00 pm Bank of America Healthcare Conference
2023-05-03 08:00 am Q1 2023 Earnings Call
2023-05-03 06:30 am Q1 2023 Earnings Release
2023-03-29 10:30 am Stifel CNS Day
2023-03-06 09:10 am Cowen Health Care Conference
2023-02-22 08:00 am FY 2022 Earnings Call
2023-02-22 06:30 am FY 2022 Earnings Release
2023-01-10 11:15 am JP Morgan Healthcare Conference
2022-11-29 03:30 pm Evercore ISI HealthCONx Conference
2022-11-16 03:00 pm Stifel Healthcare Conference
2022-11-14 Guggenheim Healthcare Talks Immunology & Neurology Day

Annual results

Fiscal PeriodDecember 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-217
-207
-5.1%
-363
-349
-4.11%
-442
-417
-5.92%
EBIT
Million USD
Released
Forecast
Spread
-220
-211
-4.33%
-368
-358
-2.78%
-447
-421
-6.3%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-225
-222
-1.41%
-351
-356
1.27%
-432
-404
-7.02%
Net income
Million USD
Released
Forecast
Spread
-225
-222
-1.38%
-352
-356
1.14%
-433
-405
-6.9%
EPS
USD
Released
Forecast
Spread
-1,65
-1,61
-2.37%
-2,32
-2,35
1.1%
-2,67
-2,50
-6.61%
Announcement Date01/03/2222/02/2327/02/24

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-93,8
-93,3
-0.53%
-106
-94,4
-12.24%






-110
-104
-5.27%
-138
-108
-27.83%



EBIT
Million USD
Released
Forecast
Spread
-95,1
-93,3
-1.86%
-107
-100
-6.89%
-99,6
-109
8.39%
-96,8
-109
10.84%
-111
-103
-7.61%
-140
-113
-23.37%
-143
-119
-19.46%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-99,9
-94,7
-5.55%
-92,6
-98,1
5.54%
-104
-110
5.61%
-99,4
-111
10.17%
-96,2
-103
6.56%
-132
-104
-27.18%
-132
-110
-19.62%
Net income
Million USD
Released
Forecast
Spread
-99,9
-96,0
-4.1%
-92,8
-97,5
4.83%
-104
-106
1.61%
-99,5
-109
8.9%
-96,4
-102
5.78%
-133
-105
-26.66%
-132
-110
-19.75%
EPS
USD
Released
Forecast
Spread
-0,66
-0,62
-6.48%
-0,59
-0,62
5.45%
-0,67
-0,67
0.72%
-0,63
-0,69
8.32%
-0,61
-0,65
5.83%
-0,76
-0,60
-26.62%
-0,73
-0,61
-19.39%
Announcement Date08/11/2222/02/2303/05/2302/08/2301/11/2327/02/2408/05/24
  1. Stock Market
  2. Equities
  3. CERE Stock
  4. Calendar Cerevel Therapeutics Holdings, Inc.